Mechanisms involved in the progression of androgen-independent prostate cancers: It is not only the cancer cell's fault

Endocrine-Related Cancer

Volumn 9, Issue 1, 2002, Pages 61-73

  Arnold, J T ^a   Isaacs, J T ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; HORMONE;

CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GROWTH REGULATION; HORMONE ACTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION;

ANDROGENS; ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 0036219874     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0090061     Document Type: Review

References (88)

1. Endometrial stromal cells regulate epithelial cell growth in vitro: A new co-culture model
2. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells
3. Selective interactions between prostate fibroblast and epithelial cells in co-culture maintain the BPH phenotype
4. Reciprocal tissue interactions in morphogenesis and hormonal responsiveness of the female reproductive tract
5. Form and function in the mammary gland: The role of extracellular matrix
6. The role of steroid hormones in prostate carcinogenesis
7. Estrogen and progestin receptors in the reproductive tract of male and female primates
8. Lessons to be learned from the androgen receptor
9. Mechanisms of androgen receptor activation and function
10. Hereditary prostate cancer: Epidemiologic and clinical features
11. Neonatal estrogen stimulates proliferation of periductal fibroblasts and alters the extracellular matrix composition in the rat prostate
12. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence
13. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly→Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels
14. Human prostate cancer model: Roles of growth factors and extracellular matrices
15. The molecular biology, endocrinology and physiology of the prostate and seminal vesicles
16. Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma
17. A mechanism for hormone- independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
18. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
19. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
20. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate
21. The possible influences of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen insensitive (Tfm) mice
22. Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interactions
23. Stromalepithelial interactions in the determination of hormonal responsiveness
24. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development
25. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6
26. Proliferative inflammatory atrophy of the prostate implications for prostatic carcinogenesis
27. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
28. Oxidative stress in chemoprevention trials
29. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer
30. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry
31. Human prostatic dehydroepiandrosterone sulfate sulfatase
32. The development of androgen-independent prostate cancer
33. Expression of bcl-2 and the progression of human and rodent prostatic cancers
34. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells
35. Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis
36. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
37. Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution
38. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression
39. 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice
40. Development of a new in vitro model for the study of benign prostatic hyperplasia
41. Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones
42. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma
43. Normal development and carcinogenesis of the prostate
44. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model
45. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines
46. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer
47. Hormonal carcinogenesis and environmental influences: Background and overview
48. Antagonistic effect of androgen on prostatic cell death
49. Role of androgens in prostatic cancer
50. The biology of hormone refractory prostate cancer: Why does it develop?
51. Etiology and disease process of benign prostatic hyperplasia
52. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system
53. Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts
54. Stromal-epithelial interactions in normal and neoplastic development
55. Quantitative assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue
56. Steroid sulfate sulfatase in human benign prostatic hyperplasia: Characterization and quantification of the enzyme in epithelium and stroma
57. Prostatic epithelium inhibiting factor (PEIF): Organ specificity and production by prostatic fibroblasts
58. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta
59. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
60. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostate cancer biomarker
61. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: Dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations
62. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat
63. The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue
64. Activation of the human androgen receptor through a protein kinase A signaling pathway
65. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase Pl
66. Hormone regulation of human prostate in organ culture
67. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma
68. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one
69. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor
70. Morphostats: A missing concept in cancer biology
71. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
72. What might a stromal response mean to prostate cancer progression?
73. Glutathione S-transferases, structure, regulation, and therapeutic implications
74. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1
75. Skin fibroblasts obtained from cancer patients display foetal-like behaviour on collagen gels
76. Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase
77. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods
78. Crucial role of cytokines in sex steroid formation in normal and tumoral tissues
79. On some general concepts in oncology with special reference to Hodgkin's disease
80. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
81. Garbage catastrophe theory of aging: Imperfect removal of oxidative damage?
82. Intratissular androgens in benign prostatic hyperplasia and prostatic cancer
83. Cadmium and prostate cancer
84. Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system
85. Rational basis for Trk inhibition therapy for prostate cancer
86. Eat to live, not live to eat
87. Growth factors and epithelial-stromal interactions in prostate cancer development
88. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor